Jubilant Pharmova’s wholly owned subsidiary -- Jubilant HollisterStier LLC (JHS) has launched its New Sterile Fill & Finish line, third at its Spokane Manufacturing Facility in Washington, US. The launch was marked by the successful production of the inaugural batch, initiating revenue generation from the new Line. The launch plays a key role in Jubilant HollisterStier’s multi-phase expansion strategy and brings an additional 50% capacity at its Spokane manufacturing facility. JHS is a leading North American pharmaceutical contract manufacturer, specialising in sterile injectables and serves top global innovator pharma companies.
Together with the commissioning of its upcoming Fourth Line, JHS is on track to double its total sterile injectable manufacturing capacity at its Spokane facility in the US. This strategic investment further reinforces JHS’ leadership in domestic US pharmaceutical manufacturing. By expanding its infrastructure and increasing onshore capacity, the company is contributing to US national health security and helping to reduce reliance on offshore supply chains - delivering a more resilient and agile pharmaceutical manufacturing ecosystem.
Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.
